FAYETTEVILLE, ARKANSAS, March 13–14 — Blazing performances in the three shortest events yielded some amazing records, but it ...

Denali Therapeutics (NASDAQ:DNLI) executives outlined near-term regulatory milestones, commercial launch preparations, and a broadening pipeline during a discussion hosted by Leerink Partners analyst ...